Cardiovascular system diseases in patients with polycystic ovary syndrome – the role of inflammation process in this pathology and possibility of early diagnosis and prevention

Aleksandra Marciniak 1, Jolanta Nawrocka Rutkowska 1, Agnieszka Brodowska 1, Berenika Wiśniewska 1, Andrzej Starczewski 1
1 - Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University, Szczecin, Poland
Ann Agric Environ Med
2016; 23 (4):
ICID: 1226842
Article type: Review article
 
 
Polycystic ovary syndrome is a disorder which affects 5–10% of women in reproductive age. PCOS is a cause of hyperandrogenism, menstrual disorders and infertility. The most common clinical symptoms are hirsutism, acne and obesity. Patients often suffer from metabolic disorders: insulin resistance, hyperinsulinemia, dislipidemia, leading to atherosclerosis and others irregularities of the metabolic syndrome. Patients are in the high risk group for cardiovascular diseases (CVD) development because of the metabolic abnormalities. Obesity is observed in 35–60% of women with PCOS. Lean women with PCOS are also exposed to a greater risk of glucose intolerance development and abnormalities in lipid profile than women without PCOS with comparable BMI. Adipocytes are the source of many compounds of the paracrine and endocrine activity. Some of them are also markers and mediators of inflammation. Increased levels of proinflammatory cytokines in blood can promote atherosclerosis and cardiovascular disease. Markers: IL-18, TNF, IL-6 and hs-CRP are often elevated in patients with polycystic ovary syndrome. An increase in inflammatory markers may be an early indicator of the risk of developing insulin resistance and atherosclerosis, and may become a useful prognostic and therapeutic tool for monitoring patients with PCOS: lean and those with overweight and obesity. Assessment of the concentrations of inflammatory markers may become a very useful test in evaluating the risk of developing atherosclerosis and cardiovascular disease, long before their clinical manifestation. It will also allow for the appropriate prophylaxis.
DOI: 10.5604/12321966.1226842
PMID 28030919 - click here to show this article in PubMed
  FULL TEXT STATS

Recommend this article to:

Name:
E-mail:
From:
Language:


Related articles in IndexCopernicus™
     Inflammation [872 related records]
     obesity, [6 related records]
     insulin resistance [25 related records]
     CVD [20 related records]
     PCOS [2 related records]



 

Related articles

F Tehrani, S Minooee,
VISCERAL ADIPOSITY INDEX (VAI), AS THE BEST PREDIC...
Background: Considering the limited population-based studies and lack of a general consensus on the most sensitive and precise predictor of insulin resistance and metabolic syndrome in the women with polycystic ovary syndrome (PCOS), the present stud...
ABSTRACT
 , ,
 Current trends in treatment of obesity in Ka...
 Our study finds out drug usage trends in over weight and obese patients without any compelling indications in Karachi, looks for deviations of current practices from evidence based antihypertensive therapeutic guidelines and identifies not only...
ABSTRACT
F Biçici, S Berksoy Hayta,
Psoriasisli hastalarda uyku kalitesinin değerlend...
Amaç: Psoriasis uyku bozuklukları ve mesleki performans gibi pek çok günlük aktivitenin bozulmasına neden olur. Uyku kalitesi kişinin yaşam kalitesini belirleyen başlıca faktörlerden biridir. Psoriasiste uyku kalitesiyle ilgili çalışmal...
ABSTRACT